Sign Up to like & get
recommendations!
0
Published in 2017 at "Acta biomaterialia"
DOI: 10.1016/j.actbio.2017.10.024
Abstract: Most peptide drugs have short half-lives, necessitating frequent injections that may induce skin sensitivity reactions; therefore, versatile prolonged-release delivery platforms are urgently needed. Here, we focused on an oxidatively and thermally responsive recombinant elastin-like polypeptide…
read more here.
Keywords:
peptide;
depot;
hydrogel;
fusion inhibitor ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.8b00609
Abstract: New therapeutic alternatives to fight against the spread of HIV-1 are based on peptides designed to inhibit the early steps of HIV-1 fusion in target cells. However, drawbacks, such as bioavailability, short half-life, rapid clearance,…
read more here.
Keywords:
inhibitor peptide;
hiv fusion;
fusion inhibitor;
fusion ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15040424
Abstract: Recently, a series of highly effective peptide- or protein-based HIV fusion inhibitors have been identified. However, due to their short half-life, their clinical application is limited. Therefore, the development of long-acting HIV fusion inhibitors is…
read more here.
Keywords:
fusion inhibitor;
fusion;
hiv fusion;
protein based ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Viruses"
DOI: 10.3390/v14040655
Abstract: The coronavirus disease 2019 (COVID-19) pandemic caused by infection of SARS-CoV-2 and its variants has posed serious threats to global public health, thus calling for the development of potent and broad-spectrum antivirals. We previously designed…
read more here.
Keywords:
half life;
coronavirus;
fusion inhibitor;
pan ... See more keywords